- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.02. | Madrigal builds in MASH with $4.4bn+ Ribo alliance | ||
| 11.02. | Inept digital interaction undermining pharma with clinicians | ||
| 11.02. | Novo Nordisk's Wegovy pill ad 'misleading', says FDA | ||
| 11.02. | Moderna cries foul as FDA blocks filing of mRNA flu shot | ||
| 11.02. | UK moves ahead with GP patient data sharing plan | ||
| 10.02. | FDA kicks off review of Takeda's narcolepsy hopeful | ||
| 10.02. | Kailera, Hengrui stake claim to oral weight loss category | ||
| 10.02. | AstraZeneca raises guidance on stellar cancer drugs growth | ||
| 10.02. | Takeda signs $1.7bn AI alliance with Iambic | ||
| 10.02. | Dismay as FDA blocks Regenxbio's Hunter syndrome therapy | ||
| 10.02. | Lupin settles Myrbetriq patent spat with Astellas for $90m | ||
| 09.02. | Lilly strikes again, buying CAR-T firm Orna for $2.4bn | ||
| 09.02. | Data builds on Roche's dominance in primary progressive MS | ||
| 09.02. | Novartis breaks ground on San Diego biomedical R&D site | ||
| 09.02. | Lilly strikes $8.8bn-plus alliance with China's Innovent | ||
| 09.02. | Novo Nordisk rises as Hims & Hers backs down on oral GLP-1 | ||
| 06.02. | Leqembi starts to deliver for Eisai and Biogen | ||
| 06.02. | Bayer reveals data behind asundexian's stroke win | ||
| 06.02. | White House's TrumpRx platform has arrived | ||
| 05.02. | Hims & Hers copies Novo Nordisk's new Wegovy pill | ||
| 05.02. | Flagship's AI-focused Generate Biomedicines files IPO | ||
| 05.02. | Amgen baulks at FDA request to withdraw Tavneos | ||
| 05.02. | Grail multi-cancer test taps into Hims & Hers network | ||
| 05.02. | Abbott's wireless heart failure sensor cleared for NHS use | ||
| 05.02. | Eikon, Veradermics close IPOs, as Salspera joins queue |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.